Department of Obstetrics and Gynecology, University of Regensburg, 93053 Regensburg, Germany.
Gynecol Endocrinol. 2010 Jan;26(1):4-9. doi: 10.3109/09513590903159573.
Uterine fibroids are the most common benign tumors of the female genital tract. Steroid hormones, especially estradiol and progesterone, play an important role in the pathobiology of this frequent disease. Recent studies suggested that both expression levels and polymorphisms of estrogen receptor (ER) alpha and beta might affect development of uterine fibroids. In this study, we tested whether single nucleotide polymorphisms (SNPs) in the promoter of estrogen receptor beta gene (ESR2) are associated with susceptibility to uterine fibroids. For this purpose, we compared the frequency of three SNPs in the promoter region of ESR2 gene (rs2987983, rs3020450 and rs3020449) in 101 women with uterine fibroids and 102 healthy women serving as controls by means of allele-specific tetra-primer polymerase chain reaction (PCR). Regarding allele frequency, allele positivity, genotype and haplotype frequencies of these SNPs we did not observe any significant difference between healthy women and women with uterine fibroids. In conclusion, our data clearly suggest that the tested SNPs in the promotor region of human ESR2 gene are not associated with the development of uterine fibroids.
子宫肌瘤是女性生殖道最常见的良性肿瘤。甾体激素,特别是雌二醇和孕酮,在这种常见疾病的病理生物学中起着重要作用。最近的研究表明,雌激素受体 (ER) α和β的表达水平和多态性可能影响子宫肌瘤的发生。在这项研究中,我们测试了雌激素受体β基因 (ESR2) 启动子中的单核苷酸多态性 (SNP) 是否与子宫肌瘤的易感性相关。为此,我们通过等位基因特异性四引物聚合酶链反应 (PCR) 比较了 101 名子宫肌瘤妇女和 102 名健康对照妇女 ESR2 基因启动子区域中三个 SNP(rs2987983、rs3020450 和 rs3020449)的频率。关于这些 SNP 的等位基因频率、等位基因阳性率、基因型和单倍型频率,我们在健康妇女和子宫肌瘤妇女之间没有观察到任何显著差异。总之,我们的数据清楚地表明,人 ESR2 基因启动子区域中测试的 SNP 与子宫肌瘤的发生无关。